Cover: An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California

An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California

Published In: Journal of Drug Policy Analysis, v. 4, no. 1, article 1, 2011, p. 1-16

by Helen Nunberg, Beau Kilmer, Rosalie Liccardo Pacula, James R. Burgdorf

Read More

Access further information on this document at www.bepress.com

This study was published in a peer-reviewed scholarly journal. The full text of the study can be found at the link above.

Abstract

While 15 states and the District of Columbia provide allowances for medical marijuana, little is known about the individuals who seek a physician's recommendation to use marijuana. This study provides descriptive information about 1,655 applicants in California who sought a physician's recommendation for medical marijuana, the conditions for which they sought treatment, and the diagnoses made by the physicians. It presents a systematic analysis of physician records and questionnaires obtained from consecutive applicants seen during a three-month period at nine medical marijuana specialty practices operating throughout the state. The analysis yields insights that may be useful for future research on medical marijuana and marijuana policy, including: 1) very few of those who sought a recommendation had cancer, HIV/AIDS, glaucoma, or multiple sclerosis; 2) most applicants presented with chronic pain, mental health conditions, or insomnia; and 3) half of the applicants reported using marijuana as a substitute for prescription drugs.

Research conducted by

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.